Frank Rimerman Advisors’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.05M Sell
122,082
-400
-0.3% -$11.3K 0.2% 84
2025
Q4
$3.85M Buy
122,482
+93
+0.1% +$3.08K 0.24% 61
2025
Q3
$4.37M Buy
122,389
+307
+0.3% +$14K 0.28% 56
2025
Q2
$7.03M Hold
122,082
0.47% 28
2025
Q1
$7.11M Sell
122,082
-22
-0% -$1.5K 0.56% 26
2024
Q4
$9.83M Hold
122,104
0.71% 20
2024
Q3
$9.78M Buy
122,104
+22
+0% +$1.56K 0.69% 21
2024
Q2
$7.46M Sell
122,082
-70,000
-36% -$4.16M 0.53% 25
2024
Q1
$9.49M Sell
192,082
-264,871
-58% -$12.6M 1.83% 12
2023
Q4
$19.2M Hold
456,953
4% 8
2023
Q3
$15M Hold
456,953
3.63% 8
2023
Q2
$16.2M Hold
456,953
3.86% 7
2023
Q1
$13M Sell
456,953
-75,860
-14% -$2.68M 3.59% 6
2022
Q4
$22.1M Sell
532,813
-40,835
-7% -$1.75M 6.89% 5
2022
Q3
$23.8M Sell
573,648
-237,975
-29% -$9.49M 8.58% 2
2022
Q2
$26.5M Buy
+811,623
New +$29.5M 10.13% 2

Other funds holding PRCT